查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521205

基於腫瘤學的體內 CRO 市場報告，按適應症（血癌、實體瘤等）、模型（同種、異種移植、患者衍生異種移植 (PDX) 等）、應用（醫院、康復中心）和地區 2024- 2032

Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球腫瘤體內CRO市場規模達到12億美元。

腫瘤學是指使用活體組織切片、內視鏡檢查、X 光、電腦斷層掃描(CT) 掃描、磁振造影(MRI)、正子斷層掃描(PET) 掃描和超音波研究、診斷和治療癌症的醫學分支。它為患者提供荷爾蒙療法、免疫療法、放射療法和口服療法，以耐受和減輕癌症的副作用。目前，由於合約研究組織 (CRO) 開發了多種治療癌症的研究化合物，全球對基於腫瘤學的體內 CRO 的需求不斷增加。

基於腫瘤學的體內 CRO 市場趨勢：

全球癌症盛行率不斷上升是推動市場的關鍵因素之一。此外，全球多個國家的政府正在廣泛投資於研發（R&D）活動。再加上合約研究組織 (CRO) 不斷提高的癌症治療專業知識，正在推動市場的成長。此外，用於操縱脫氧核糖核酸（DNA）和改變生物體特徵的基因工程創新也有所增加。再加上對調節細胞增殖、生長和分化的癌基因研究的日益關注，正在對市場產生積極影響。除此之外，藥品的廣泛供應以及醫療保健行業的不斷擴大，正在刺激全球對基於腫瘤學的體內 CRO 的需求。除此之外，與內部研究相比，合約研究組織 (CRO) 提供的成本效率為行業投資者提供了利潤豐厚的成長機會。此外，為了確保癌症患者的安全，醫療保健產業擴大採用遠距醫療和虛擬臨床試驗。預計這將促進市場的成長。

本報告回答的關鍵問題

  • 2023 年全球腫瘤體內 CRO 市場規模有多大？ 2024-2032年全球腫瘤體內CRO市場的預期成長率為何？
  • 推動全球腫瘤學體內 CRO 市場的關鍵因素是什麼？
  • COVID-19 對全球腫瘤體內 CRO 市場有何影響？
  • 根據此適應症，全球腫瘤學體內 CRO 市場的細分如何？
  • 基於模型的全球腫瘤體內 CRO 市場的細分是怎樣的？
  • 全球腫瘤體內 CRO 市場的關鍵區域有哪些？
  • 全球腫瘤體內 CRO 市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球基於腫瘤學的體內 CRO 市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依跡象

  • 血癌
    • 市場走向
    • 市場預測
  • 實體腫瘤
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按模式

  • 同系
    • 市場走向
    • 市場預測
  • 異種移植
    • 市場走向
    • 市場預測
  • 患者來源的異種移植物 (PDX)
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 醫院
    • 市場走向
    • 市場預測
  • 復健中心
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Crown Bioscience Inc.
    • Eurofins Scientific
    • Evotec SE
    • ICON Plc
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • Living Tumor Laboratory
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • WuXi AppTec
    • Xentech
Product Code: SR112024A5438

The global oncology based in-vivo CRO market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032.

Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.

Oncology Based In-Vivo CRO Market Trends:

The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, model and application.

Breakup by Indication:

Blood Cancer

Solid Tumors

Others

Breakup by Model:

Syngeneic

Xenograft

Patient Derived Xenograft (PDX)

Others

Breakup by Application:

Hospitals

Rehabilitation Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.

Key Questions Answered in This Report

  • 1. What was the size of the global oncology based in-vivo CRO market in 2023?
  • 2. What is the expected growth rate of the global oncology based in-vivo CRO market during 2024-2032?
  • 3. What are the key factors driving the global oncology based in-vivo CRO market?
  • 4. What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
  • 5. What is the breakup of the global oncology based in-vivo CRO market based on the indication?
  • 6. What is the breakup of the global oncology based in-vivo CRO market based on the model?
  • 7. What are the key regions in the global oncology based in-vivo CRO market?
  • 8. Who are the key players/companies in the global oncology based in-vivo CRO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Based In-Vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Blood Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tumors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Model

  • 7.1 Syngeneic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Xenograft
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Patient Derived Xenograft (PDX)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Rehabilitation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Champions Oncology Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Charles River Laboratories International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Crown Bioscience Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Evotec SE
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 ICON Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Living Tumor Laboratory
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Taconic Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 The Jackson Laboratory
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Xentech
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2023
  • Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
  • Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2024-2032
  • Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
  • Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players